Department of Biochemistry and Biotechnology, University of Thessaly, Greece.
Bioorg Chem. 2010 Dec;38(6):285-93. doi: 10.1016/j.bioorg.2010.08.001. Epub 2010 Aug 17.
The 3-deoxy-3-fluoro-6-S-(2-S-pyridyl)-6-thio-β-D-glucopyranosyl nucleoside analogs 7 were prepared via two facile synthetic routes. Their precursors, 3-fluoro-6-thio-glucopyranosyl nucleosides 5a-e, were obtained by the sequence of deacetylation of 3-deoxy-3-fluoro-β-D-glucopyranosyl nucleosides 2a-e, selective tosylation of the primary OH of 3 and finally treatment with potassium thioacetate. The desired thiolpyridine protected analogs 7a-c,f,g were obtained by the sequence of deacetylation of 5a-c followed by thiopyridinylation and/or condensation of the corresponding heterocyclic bases with the newly synthesized peracetylated 6-S-(2-S-pyridyl) sugar precursor 13, which was obtained via a novel synthetic route from glycosyl donor 12. None of the compounds 6 and 7 showed antiviral activity, but the 5-fluorouracil derivative 7c and particularly the uracil derivative 7b were endowed with an interesting and selective cytostatic action against a variety of murine and human tumor cell cultures.
3-去氧-3-氟-6-S-(2-吡啶基)-6-硫代-β-D-葡糖苷核苷类似物 7 通过两种简便的合成路线制备。它们的前体,3-氟-6-硫代-β-D-葡糖苷核苷 5a-e,是通过 3-脱氧-3-氟-β-D-葡糖苷核苷 2a-e 的脱乙酰化序列、3 位的选择性甲苯磺酰化以及最后与硫代乙酰胺钾反应得到的。所需的硫代吡啶保护类似物 7a-c,f,g 是通过 5a-c 的脱乙酰化序列得到的,然后进行硫代吡啶化和/或与新合成的全乙酰化 6-S-(2-吡啶基)糖前体 13 进行杂环碱基缩合得到,该前体通过糖苷供体 12 的新合成路线得到。化合物 6 和 7 均无抗病毒活性,但 5-氟尿嘧啶衍生物 7c 特别是尿嘧啶衍生物 7b 对多种鼠和人肿瘤细胞培养物具有有趣和选择性的细胞抑制作用。